Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Mar;69(3):632–642. doi: 10.1172/JCI110490

Relationship of Cell-Cycle Expression of Ia-like Antigenic Determinants on Normal and Leukemia Human Granulocyte-Macrophage Progenitor Cells to Regulation In Vitro by Acidic Isoferritins

Hal E Broxmeyer 1
PMCID: PMC371020  PMID: 6174548

Abstract

An association has been established between human Ia-like (Ia) antigenic determinants, expression during DNA synthesis on granulocyte-macrophage colony forming cells (CFU-GM) and the regulatory action of acidic isoferritins in vitro. Treatment of human bone marrow cells with monoclonal-anti-Ia-like (Ia) plus complement inhibited colony and cluster formation by ∼50% but did not affect pre-CFU-GM. Reduction of colonies and clusters was similar whether bone marrow cells were exposed to anti-Ia plus complement, high specific activity tritiated thymidine (3HTdr) or acidic isoferritins. No further decrease was apparent with 3HTdr or acidic isoferritins after Ia-antigen+ CFU-GM were removed, or with anti-Ia plus complement or acidic isoferritins after DNA synthetic phase (S-phase) CFU-GM were removed. Anti-Ia, without complement, did not reduce colony or cluster formation but did block the inhibitory action of acidic isoferritins. A relationship existed between Ia antigens and the activity of acidic isoferritins in the following ways: (a) The apparent loss of Ia-antigens from CFU-GM by 5 h in culture at 37°C, but not at 27° or 4°C, was associated with nonresponsiveness to inhibition with acidic isoferritins, (b) Ia-antigen−, noncycling pre-CFU-GM that were insensitive to acidic isoferritins could generate a population of Ia-antigen+ cycling CFU-GM in vitro that were responsive to inhibition by acidic isoferritins, and (c) nondetectability of Ia-antigens on CFU-GM from patients with leukemia was associated with nonresponsiveness to inhibition by acidic isoferritins. These results implicate Ia-antigen+ progenitor cells in the regulation of myelopoiesis in vitro and demonstrate that absence of Ia-antigens on patient CFU-GM is associated with imbalances in normal regulatory interactions in vitro. These findings may be of relevance to normal regulation and to the progression of leukemia.

Full text

PDF
632

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beller D. I., Unanue E. R. Regulation of macrophage populations. II. Synthesis and expression of Ia antigens by peritoneal exudate macrophages is a transient event. J Immunol. 1981 Jan;126(1):263–269. [PubMed] [Google Scholar]
  2. Bognacki J., Broxmeyer H. E., Lobue J. Isolation and biochemical characterization of leukemia-associated inhibitory activity that suppresses colony and cluster formation of cells. Biochim Biophys Acta. 1981 Jan 21;672(2):176–190. doi: 10.1016/0304-4165(81)90391-3. [DOI] [PubMed] [Google Scholar]
  3. Broxmeyer H. E., Bognacki J., Dorner M. H., de Sousa M. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages. J Exp Med. 1981 Jun 1;153(6):1426–1444. doi: 10.1084/jem.153.6.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Broxmeyer H. E., Grossbard E., Jacobsen N., Moore M. A. Evidence for a proliferative advantage of human leukemia colony-forming cells in vitro. J Natl Cancer Inst. 1978 Mar;60(3):513–521. doi: 10.1093/jnci/60.3.513. [DOI] [PubMed] [Google Scholar]
  5. Broxmeyer H. E., Grossbard E., Jacobsen N., Moore M. A. Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemia. N Engl J Med. 1979 Aug 16;301(7):346–351. doi: 10.1056/NEJM197908163010702. [DOI] [PubMed] [Google Scholar]
  6. Broxmeyer H. E., Jacobsen N., Kurland J., Mendelsohn N., Moore A. S. In vitro suppression of normal granulocytic stem cells by inhibitory activity derived from human leukemia cells. J Natl Cancer Inst. 1978 Mar;60(3):497–511. doi: 10.1093/jnci/60.3.497. [DOI] [PubMed] [Google Scholar]
  7. Broxmeyer H. E. Lactoferrin acts on Ia-like antigen-positive subpopulations of human monocytes to inhibit production of colony stimulatory activity in vitro. J Clin Invest. 1979 Dec;64(6):1717–1720. doi: 10.1172/JCI109635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Broxmeyer H. E., Moore M. A. Communication between white cells and the abnormalities of this in leukemia. Biochim Biophys Acta. 1978 Oct 27;516(2):129–166. doi: 10.1016/0304-419x(78)90006-9. [DOI] [PubMed] [Google Scholar]
  9. Broxmeyer H. E., Ralph P., Gilbertson S., Margolis V. B. Induction of leukemia-associated inhibitory activity and bone marrow granulocyte-macrophage progenitor cell alterations during infection with Abelson virus. Cancer Res. 1980 Nov;40(11):3928–3933. [PubMed] [Google Scholar]
  10. Broxmeyer H. E., Ralph P., Margolis V. B., Nakoinz I., Meyers P., Kapoor N., Moore M. A. Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA). Leuk Res. 1979;3(4):193–203. doi: 10.1016/0145-2126(79)90042-0. [DOI] [PubMed] [Google Scholar]
  11. Cline M. J., Billing R. Antigens expressed by human B lymphocytes and myeloid stem cells. J Exp Med. 1977 Oct 1;146(4):1143–1145. doi: 10.1084/jem.146.4.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DiPersio J. F., Brennan J. K., Lichtman M. A., Abboud C. N., Kirkpatrick F. H. The fractionation, characterization, and subcellular localization of colony-stimulating activities released by the human monocyte-like cell line, GCT. Blood. 1980 Oct;56(4):717–727. [PubMed] [Google Scholar]
  13. Fitchen J. H., Ferrone S., Quaranta V., Molinaro G. A., Cline M. J. Monoclonal antibodies to HLA-A,B, and Ia-like antigens inhibit colony formation by human myeloid progenitor cells. J Immunol. 1980 Nov;125(5):2004–2008. [PubMed] [Google Scholar]
  14. Grumet F. C., Charron D. J., Fendly B. M., Levy R., Ness D. B. HLA-DR epitope region definition by use of monoclonal antibody probes. J Immunol. 1980 Dec;125(6):2785–2789. [PubMed] [Google Scholar]
  15. Jacobsen N., Broxmeyer H. E., Grossbard E., Moore M. A. Colony-forming units in diffusion chambers (CFU-d) and colony-forming units in agar culture (CFU-c) obtained from normal human bone marrow: a possible parent-progeny relationship. Cell Tissue Kinet. 1979 Mar;12(2):213–226. doi: 10.1111/j.1365-2184.1979.tb00127.x. [DOI] [PubMed] [Google Scholar]
  16. Janossy G., Francis G. E., Capellaro D., Goldstone A. H., Greaves M. F. Cell sorter analysis of leukaemia-associated antigens on human myeloid precursors. Nature. 1978 Nov 9;276(5684):176–178. doi: 10.1038/276176a0. [DOI] [PubMed] [Google Scholar]
  17. Lampson L. A., Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol. 1980 Jul;125(1):293–299. [PubMed] [Google Scholar]
  18. Lanier L. L., Warner N. L. Cell cycle related heterogeneity of Ia antigen expression on a murine B lymphoma cell line:analysis by flow cytometry. J Immunol. 1981 Feb;126(2):626–631. [PubMed] [Google Scholar]
  19. Marcelletti J., Furmanski P. A murine model system for the study of the human leukemia-associated inhibitory activity. Blood. 1980 Jul;56(1):134–137. [PubMed] [Google Scholar]
  20. Moore M. A., Broxmeyer H. E., Sheridan A. P., Meyers P. A., Jacobsen N., Winchester R. J. Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells. Blood. 1980 Apr;55(4):682–690. [PubMed] [Google Scholar]
  21. Pesando J. M., Nadler L. M., Lazarus H., Tomaselli K. J., Stashenko P., Ritz J., Levine H., Yunis E. J., Schlossman S. F. Human cell lines express multiple populations of Ia-like molecules. Hum Immunol. 1981 Aug;3(1):67–76. doi: 10.1016/0198-8859(81)90044-6. [DOI] [PubMed] [Google Scholar]
  22. Quaranta V., Pellegrino M. A., Ferrone S. Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens. J Immunol. 1981 Feb;126(2):548–552. [PubMed] [Google Scholar]
  23. Reinherz E. L., Kung P. C., Pesando J. M., Ritz J., Goldstein G., Schlossman S. F. Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med. 1979 Dec 1;150(6):1472–1482. doi: 10.1084/jem.150.6.1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Steeg P. S., Moore R. N., Oppenheim J. J. Regulation of murine macrophage Ia-antigen expression by products of activated spleen cells. J Exp Med. 1980 Dec 1;152(6):1734–1744. doi: 10.1084/jem.152.6.1734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Steinman R. M., Nogueira N., Witmer M. D., Tydings J. D., Mellman I. S. Lymphokine enhances the expression and synthesis of Ia antigens on cultured mouse peritoneal macrophages. J Exp Med. 1980 Nov 1;152(5):1248–1261. doi: 10.1084/jem.152.5.1248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Taetle R. Acidic isoferritins (leukemia-associated inhibitory activity) fail to inhibit blast proliferation in acute myelogenous leukemia. Blood. 1981 Sep;58(3):653–657. [PubMed] [Google Scholar]
  27. Winchester R. J., Kunkel H. G. The human Ia system. Adv Immunol. 1979;28:221–292. [PubMed] [Google Scholar]
  28. Winchester R. J., Ross G. D., Jarowski C. I., Wang C. Y., Halper J., Broxmeyer H. E. Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4012–4016. doi: 10.1073/pnas.74.9.4012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES